JP2022552870A5 - - Google Patents

Info

Publication number
JP2022552870A5
JP2022552870A5 JP2022523434A JP2022523434A JP2022552870A5 JP 2022552870 A5 JP2022552870 A5 JP 2022552870A5 JP 2022523434 A JP2022523434 A JP 2022523434A JP 2022523434 A JP2022523434 A JP 2022523434A JP 2022552870 A5 JP2022552870 A5 JP 2022552870A5
Authority
JP
Japan
Prior art keywords
patent document
international
application
prior
documents cited
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022523434A
Other languages
English (en)
Japanese (ja)
Other versions
JP7711959B2 (ja
JP2022552870A (ja
Filing date
Publication date
Priority claimed from EP19204420.4A external-priority patent/EP3812465A1/en
Application filed filed Critical
Publication of JP2022552870A publication Critical patent/JP2022552870A/ja
Publication of JP2022552870A5 publication Critical patent/JP2022552870A5/ja
Application granted granted Critical
Publication of JP7711959B2 publication Critical patent/JP7711959B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022523434A 2019-10-21 2020-10-20 改変型アデノウイルスヘキソンタンパク質を有するアデノウイルス Active JP7711959B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19204420.4A EP3812465A1 (en) 2019-10-21 2019-10-21 Adenovirus comprising a modified adenovirus hexon protein
EP19204420.4 2019-10-21
PCT/EP2020/079494 WO2021078735A1 (en) 2019-10-21 2020-10-20 Adenovirus comprising a modified adenovirus hexon protein

Publications (3)

Publication Number Publication Date
JP2022552870A JP2022552870A (ja) 2022-12-20
JP2022552870A5 true JP2022552870A5 (cg-RX-API-DMAC7.html) 2023-10-17
JP7711959B2 JP7711959B2 (ja) 2025-07-23

Family

ID=68296308

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022523434A Active JP7711959B2 (ja) 2019-10-21 2020-10-20 改変型アデノウイルスヘキソンタンパク質を有するアデノウイルス

Country Status (5)

Country Link
US (1) US12435112B2 (cg-RX-API-DMAC7.html)
EP (3) EP3812465A1 (cg-RX-API-DMAC7.html)
JP (1) JP7711959B2 (cg-RX-API-DMAC7.html)
CA (1) CA3158189A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021078735A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024005211A1 (ja) * 2022-06-27 2024-01-04 国立大学法人大阪大学 ヘキソン改変型アデノウイルスベクター

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2236912C (en) * 1995-11-28 2006-04-25 Genvec, Inc. Vectors and methods for gene transfer to cells
AU767975B2 (en) * 1998-09-11 2003-11-27 Genvec, Inc. Alternatively targeted adenovirus
CN101437538A (zh) * 2006-04-28 2009-05-20 宾夕法尼亚州立大学托管会 修饰的腺病毒六邻体蛋白和其应用
WO2013116778A2 (en) * 2012-02-02 2013-08-08 Board Of Regents Immunogenic adenovirus
US9017672B2 (en) * 2012-05-11 2015-04-28 Immunicum Aktiebolag Hexon Tat-PTD modified adenovirus and uses thereof
EP3569253A1 (en) 2013-06-05 2019-11-20 Bellicum Pharmaceuticals, Inc. Methods for inducing partial apoptosis using caspase polypeptides
CA2948751A1 (en) 2014-05-14 2015-11-19 The University Court Of The University Of Aberdeen Methods of obtaining islet cells
ES2899913T3 (es) * 2014-09-24 2022-03-15 Salk Inst For Biological Studi Virus tumorales oncolíticos y métodos de uso
EP3247807B1 (en) * 2015-01-20 2020-12-16 Adcure Biotechnologies, LLC. Detargeted adenovirus variants and related methods
GB201802539D0 (en) * 2018-02-16 2018-04-04 Univ College Cardiff Consultants Ltd Modified adenoviruses

Similar Documents

Publication Publication Date Title
JP2021524958A5 (cg-RX-API-DMAC7.html)
JP2021521987A5 (cg-RX-API-DMAC7.html)
JP2022510882A5 (cg-RX-API-DMAC7.html)
JP2021510107A5 (cg-RX-API-DMAC7.html)
JP2023553869A5 (cg-RX-API-DMAC7.html)
JP2020531120A5 (cg-RX-API-DMAC7.html)
CN110352188A (zh) 氟代烯丙胺衍生物及其用途
JP2020514283A5 (cg-RX-API-DMAC7.html)
JP2021519175A5 (cg-RX-API-DMAC7.html)
JP2016537341A5 (cg-RX-API-DMAC7.html)
JP2020531121A5 (cg-RX-API-DMAC7.html)
JP2018035160A5 (cg-RX-API-DMAC7.html)
JP2015513897A5 (cg-RX-API-DMAC7.html)
JP2019536800A5 (cg-RX-API-DMAC7.html)
JP2021528488A5 (cg-RX-API-DMAC7.html)
JP2023527970A5 (cg-RX-API-DMAC7.html)
JP2016508852A5 (cg-RX-API-DMAC7.html)
JP2007538024A5 (cg-RX-API-DMAC7.html)
JP2017222722A5 (cg-RX-API-DMAC7.html)
JP2021529732A5 (cg-RX-API-DMAC7.html)
JP2023541928A5 (cg-RX-API-DMAC7.html)
TW202019454A (zh) 病毒去活化劑
Malviya et al. Chronotherapeutic dosage form for the effective treatment of disease
JP2025502064A5 (cg-RX-API-DMAC7.html)
JP2024517807A5 (cg-RX-API-DMAC7.html)